Cargando…
LAT1 inhibitor JPH203 sensitizes cancer cells to radiation by enhancing radiation-induced cellular senescence
L-type amino acid transporter 1 (LAT1) is important for transporting neutral amino acids into cells. LAT1 expression is correlated with cancer malignancy, suggesting that LAT1 is a promising target for cancer therapy. JPH203, a potential novel drug targeting LAT1, has been shown to suppress tumor gr...
Autores principales: | Bo, Tomoki, Kobayashi, Sho, Inanami, Osamu, Fujii, Junichi, Nakajima, Osamu, Ito, Tsunekata, Yasui, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405945/ https://www.ncbi.nlm.nih.gov/pubmed/34461558 http://dx.doi.org/10.1016/j.tranon.2021.101212 |
Ejemplares similares
-
Insights into the Transport Cycle of LAT1 and Interaction with the Inhibitor JPH203
por: Brunocilla, Chiara, et al.
Publicado: (2023) -
The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model
por: Häfliger, Pascal, et al.
Publicado: (2018) -
DNA damage response in vascular endothelial senescence: Implication for radiation-induced cardiovascular diseases
por: Nagane, Masaki, et al.
Publicado: (2021) -
The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis
por: Otani, Rina, et al.
Publicado: (2023) -
The Selective LAT1 Inhibitor JPH203 Enhances Mitochondrial Metabolism and Content in Insulin-Sensitive and Insulin-Resistant C2C12 Myotubes
por: Rivera, Caroline N., et al.
Publicado: (2023)